Abstract: The present invention, therefore, is directed to an antimicrobial compositions that decreases the bioavailability of iron by introducing a higher-affinity iron-selective chelating agent capable of competing with microbial siderophores. In one aspect, the present invention relates to an antimicrobial composition including a potentiating antimicrobial composition including one or more antimicrobial agents and a chelator having a weight ratio of the antimicrobial agent to the chelator from about 1:1000 to about 1000:1.
Type:
Grant
Filed:
October 14, 2013
Date of Patent:
October 8, 2019
Assignee:
Arch Chemicals, Inc.
Inventors:
George Polson, Jody Jourden, Qi Zheng, Regina M. Prioli, Diana Ciccognani, Sungmee Choi
Abstract: The present invention concerns an anticoagulation fluid comprising 10-40 mM citrate and 0.1-4 mM phosphate. The anticoagulation fluid is to be used for regional citrate anticoagulation in an extracorporeal blood circuit. The anticoagulation fluid may be combined with at least one treatment fluid in the dialysis treatment, and it may be included in a system for regional citrate anticoagulation in an extracorporeal blood circuit.
Abstract: The invention provides a method of treating sensitive teeth comprising attaching a sealant composition comprising a basic amino acid to a person's tooth and allowing the basic amino acid to be slowly released over time in order to reduce chrome and/or acute tooth sensitivity together with compositions and methods of use.
Type:
Grant
Filed:
February 6, 2009
Date of Patent:
August 27, 2019
Assignee:
Colgate-Palmolive Company
Inventors:
Michael Prencipe, Richard Scott Robinson, Rajnish Kohli, Richard J. Sullivan
Abstract: The present invention belongs to the field of bio-pharmaceutical material preparation technology, and relates to a preparation method of albumin nanoparticle carrier entrapping taxane-typed drug. This preparation method rapidly forms nanoparticle solution of albumin entrapping taxane-typed drug under room temperature by adding solvent as the medium. Next, by the second time of freeze-drying, stable powder of albumin nanoparticles entrapping taxane-typed drug is obtained. The final freeze-dried powder only includes two components: albumin and taxane-typed drug. The particles are in regular spherical shape, and the diameter of particle is less than 100 nm. The present invention has high drug loading ratio and entrapment efficiency. The experiment of releasing in vitro shows that the present invention has a good slow-release effect. Taxane-typed drug nanoparticles provided by the present invention improves the safety and compliance of this type of reagent.
Type:
Grant
Filed:
May 20, 2017
Date of Patent:
July 30, 2019
Assignee:
Zhejiang Academy of Forestry
Inventors:
Ru Fang, Shaozong Yang, Hua Qian, Yanbin Wang
Abstract: A pharmaceutical composition comprises multiparticulates comprising a melt-congeal core and a solid amorphous dispersion layer of a poorly water soluble drug and polymer. The multiparticulates are suitable for improving bioavailability of poorly water soluble drugs. The melt-congeal cores facilitate application of the solid amorphous dispersion layer, and allow incorporation of additional optional components to the core so as to adjust the release of drug from the multiparticulate.
Type:
Grant
Filed:
November 19, 2007
Date of Patent:
July 23, 2019
Assignee:
Ben Research, Inc.
Inventors:
Dwayne Thomas Friesen, Leah E. Appel, Joshua Richard Shockey, Sanjay Konagurthu, Edward Dennis LaChapelle
Abstract: The present invention relates to a particulate material and a solid dosage form notably tablets comprising a regularly shaped calcium-containing compound such as a calcium salt as a therapeutically and/or prophylactically active substance and a pharmaceutically acceptable sugar alcohol such as, e.g., sorbitol and/or isomalt that has a micro structure as evidenced by SEM. The invention also relates to a process for the preparation of the particulate material and solid dosage form. The process involves agglomeration of the calcium-containing compound and the pharmaceutically acceptable sugar alcohol by means of roller compaction. The particulate material obtained by roller compaction is suitable for use in the further processing of the particulate material into e.g. tablets such as chewing tablets.
Type:
Grant
Filed:
September 26, 2012
Date of Patent:
July 23, 2019
Assignee:
Takeda AS
Inventors:
Jacob Mathiesen, Carsten M. Nielsen, Peder M. Olsen, Poul E. Bertelsen
Abstract: An oral care compositon is described for use in the treatment or alleviation of the symptoms of dry mouth comprising polyvinyl pyrrolidone (PVP) or a derivative thereof, an anionic mucoadhesive polymer and an orally acceptable carrier or excipient.
Abstract: Provided are nutritional supplements designed for enhancing the growth, particularly the linear growth, of pre-pubertal children with a stature measure short compared to the norm. The nutritional composition includes an energy source, arginine and a combination of micronutrients.
Abstract: What is proposed are specific tetrahydrofuran derivatives of the formula (I), fragrance and aroma substance mixtures comprising these tetrahydrofuran derivatives, their use in fragrance or aroma substance (mixture) and corresponding perfumed products.
Type:
Grant
Filed:
June 24, 2015
Date of Patent:
July 9, 2019
Assignee:
Symrise AG
Inventors:
Edison Diaz Gomez, Bernd Hölscher, Marc Mansfeld
Abstract: A biocide-free sponge cloth prewetted with a hygroscopically acting inorganic salt is provided. The spone cloth is based on regenerated cellulose which is mechanically reinforced with fibers and/or a web and includes a hygroscopically acting salt. The sponge cloth has an aw value of less than 0.80. On account of the low aw value, the sponge cloth has an antibacterial, bacteriostatic, fungicidal and/or fungistatic effect. The hygroscopically acting salt is preferably magnesium chloride. It can be combined with further inorganic salts, with low molecular weight, mono- or polyhydric alcohols, with sugars, sugar esters, mono- or polybasic carboxylic acids, esters of mono- or polybasic carboxylic acids and/or with hydrophilic polymers. The sponge cloth is preferably produced by the viscose process.
Type:
Grant
Filed:
December 14, 2015
Date of Patent:
June 18, 2019
Assignee:
Kalle GmbH
Inventors:
Leo Mans, Norbert Tüschen, Marian Peter Sklorz
Abstract: The present invention provides an intraorally rapidly disintegrating tablet that can be formed using an ordinary apparatus, that has hardness with no practical problem and that disintegrates rapidly with good feeling in the oral cavity. The present invention is intraorally rapidly disintegrating tablet produced by compression molding of a granule coated with a disintegrant, in which the granule contains a disintegrant also inside thereof and a drug except ambroxol hydrochloride inside and/or outside thereof.
Abstract: The invention is directed to methods of treating dermatological conditions, including cosmetic treatments intended to moisturize the epidermis, improve the firmness of the dermis, combat ageing of the skin. The methods include application of cosmetic or dermatological compositions containing mannoproteins as an active ingredient and/or adjuvant, to the use of said cosmetic or dermatological compositions and to cosmetic treatment methods.
Type:
Grant
Filed:
October 31, 2016
Date of Patent:
May 21, 2019
Assignee:
Lesaffre et Compagnie
Inventors:
Peter Jüsten, Dominique Marie Noëlle Borreill
Abstract: The present invention relates to a particulate material and a solid dosage form notably tablets comprising a regularly shaped calcium-containing compound such as a calcium salt as a therapeutically and/or prophylactically active substance and a pharmaceutically acceptable sugar alcohol such as, e.g., sorbitol and/or isomalt that has a micro structure as evidenced by SEM. The invention also relates to a process for the preparation of the particulate material and solid dosage form. The process involves agglomeration of the calcium-containing compound and the pharmaceutically acceptable sugar alcohol by means of roller compaction. The particulate material obtained by roller compaction is suitable for use in the further processing of the particulate material into e.g. tablets such as chewing tablets.
Type:
Grant
Filed:
May 24, 2005
Date of Patent:
April 16, 2019
Assignee:
Takeda AS
Inventors:
Jacob Mathiesen, Carsten Martini Nielsen, Peder Mohr Olsen, Poul Egon Bertelsen
Abstract: The present disclosure discloses compositions and methods for multipurpose disinfection and sterilization solutions broadly effective against multiple microbial pathogens. The present disclosure demonstrates broad spectrum antimicrobial activity against environmental and pathogenic amoeba, bacterial spores, vegetative bacteria, fungi, rickettsia, viruses, parasites and toxic microbial products. The multipurpose disinfection solutions of the present disclosure may be used alone or in combination for a variety of purposes, including disinfection of medical devices such as contact lenses, contact lens cases, surgical instruments, and dental instruments.
Type:
Grant
Filed:
September 2, 2016
Date of Patent:
April 9, 2019
Assignee:
THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND
Inventors:
Chad Roy, Rebecca Metzinger, Robert Reimers
Abstract: Fibrous antimicrobial materials for use in structures and barrier applications, such as face masks and wound dressings, have been developed from antimicrobial polymeric materials. The fibrous antimicrobial materials also are particularly suitable for use in air and water filtration. The antimicrobial polymeric materials are prepared from solid solutions of antimicrobial bisguanide compounds blended with certain thermoplastic polymers. The antimicrobial polymeric materials may be extruded into fibers or used in the particulate form for preparation of the nonwoven antimicrobial materials. The antimicrobial bisguanide compound, such as chlorhexidine, are distributed at the molecular level within at least one thermoplastic polymer, such as a polyolefin in which the antimicrobial bisguanide compound is soluble, to form a miscible blend. Methods for their formation and use also are provided.
Abstract: The present invention relates to a method of suppressing coloration of catechins, which contains adding, to catechins, a water-soluble polymer forming a water-insoluble complex with catechins, as well as hydrogel particles containing a water-insoluble complex between catechins and a polymer forming a water-insoluble complex with catechins. Further, the present invention relates to a dentifrice composition containing hydrogel particles containing catechins and a polymer forming a water-insoluble complex with catechins, a binder and water.
Type:
Grant
Filed:
April 7, 2015
Date of Patent:
February 26, 2019
Assignee:
KAO CORPORATION
Inventors:
Michiya Takagi, Satoshi Ueno, Koji Mine, Hideaki Kubo, Ikuhisa Ichimura, Gen Nakauchi, Kazushi Oshino
Abstract: A method for easily producing orodispersible tablets that secure an eluting behavior of a principal agent in the digestive tract and mask unpleasant taste in the oral cavity is provided. Provided is a method for producing orodispersible tablets which includes mixing an additive to a principal agent to form principal agent particles as a granulation process, coating the principal agent particles with a coating agent to form coated particles as a coating process, and tableting the coated particles to form tablets as a tableting process, wherein the additive used in the granulation process contains a pH regulator, and the coating agent used in the coating process contains a pH-dependent polymer dissolving at pH 5 or more.
Abstract: The present invention refers to pharmaceutical beclomethasone dipropionate compositions in modified-release gastro-resistant microspheres and to their oral use in the treatment of inflammatory pathologies of the intestinal tract. Said compositions in microspheres comprise: a) a core consisting of a microsphere of inert material; b) a first intermediate coating comprising beclomethasone dipropionate and at least one physiologically acceptable excipient; c) a second modified-release gastro-resistant coating. The present invention also refers to a process for obtaining said compositions.